Health Idea Now
Thursday, 31 January 2019
Celgene profit beats as psoriasis drug sales surge
Celgene Corp, which is being bought by Bristol-Myers Squibb Co, reported a better-than-expected fourth-quarter profit on Thursday, driven mainly by higher sales of psoriasis drug Otezla.
from Reuters: Health News https://reut.rs/2MGE8Yw
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment